IDEAS home Printed from https://ideas.repec.org/a/spr/stabio/v12y2020i3d10.1007_s12561-020-09275-2.html
   My bibliography  Save this article

Methods for Feature Selection in Down-Selection of Vaccine Regimens Based on Multivariate Immune Response Endpoints

Author

Listed:
  • Ying Huang

    (Fred Hutchinson Cancer Research Center)

  • Aliasghar Tarkhan

    (University of Washington)

Abstract

In clinical trials, it is often of interest to compare and order several candidate regimens based on multiple endpoints. For example, in HIV vaccine development, immune response profiles induced by vaccination are key for selecting vaccine regimens to advance to efficacy evaluation. Motivated by the need to rank and choose a few vaccine regimens based on their immunogenicity in phase I trials, Huang et al. (Biostatistics 18(2):230–243, 2017) proposed a ranking/filtering/selection algorithm that down-selects vaccine regimens to satisfy the superiority and non-redundancy criteria, based on multiple immune response endpoints. In practice, many candidate immune response endpoints can be correlated with each other. An important question that remains to be addressed is how to choose a parsimonious set of the available immune response endpoints to effectively compare regimens. In this paper, we propose novel algorithms for selecting immune response endpoints to be used in regimen down-selection, based on importance weights assigned to individual endpoints and their correlation structure. We show through extensive simulation studies that pre-selection of endpoints can substantially improve performance of the subsequent regimen down-selection process. The application of the proposed method is demonstrated using a real example in HIV vaccine research, although the methods are also applicable in general to clinical research for dimension reduction when comparing regimens based on multiple candidate endpoints.

Suggested Citation

  • Ying Huang & Aliasghar Tarkhan, 2020. "Methods for Feature Selection in Down-Selection of Vaccine Regimens Based on Multivariate Immune Response Endpoints," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 12(3), pages 353-375, December.
  • Handle: RePEc:spr:stabio:v:12:y:2020:i:3:d:10.1007_s12561-020-09275-2
    DOI: 10.1007/s12561-020-09275-2
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s12561-020-09275-2
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s12561-020-09275-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Ying Huang & Peter B. Gilbert, 2011. "Comparing Biomarkers as Principal Surrogate Endpoints," Biometrics, The International Biometric Society, vol. 67(4), pages 1442-1451, December.
    2. Peter B. Gilbert & Michael G. Hudgens, 2008. "Evaluating Candidate Principal Surrogate Endpoints," Biometrics, The International Biometric Society, vol. 64(4), pages 1146-1154, December.
    3. Ajit C. Tamhane, 2004. "A superiority-equivalence approach to one-sided tests on multiple endpoints in clinical trials," Biometrika, Biometrika Trust, vol. 91(3), pages 715-727, September.
    4. Daniel A. Bloch & Tze Leung Lai & Pascale Tubert-Bitter, 2001. "One-Sided Tests in Clinical Trials with Multiple Endpoints," Biometrics, The International Biometric Society, vol. 57(4), pages 1039-1047, December.
    5. Michael D. Perlman & Lang Wu, 2004. "A Note on One-Sided Tests with Multiple Endpoints," Biometrics, The International Biometric Society, vol. 60(1), pages 276-280, March.
    6. Ying Huang & Peter B. Gilbert & Julian Wolfson, 2013. "Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials," Biometrics, The International Biometric Society, vol. 69(2), pages 301-309, June.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Ying Huang & Shibasish Dasgupta, 2019. "Likelihood-Based Methods for Assessing Principal Surrogate Endpoints in Vaccine Trials," Statistics in Biosciences, Springer;International Chinese Statistical Association, vol. 11(3), pages 504-523, December.
    2. Erin E. Gabriel & Michael C. Sachs & Dean A. Follmann & Therese M‐L. Andersson, 2020. "A unified evaluation of differential vaccine efficacy," Biometrics, The International Biometric Society, vol. 76(4), pages 1053-1063, December.
    3. Ying Huang, 2018. "Evaluating principal surrogate markers in vaccine trials in the presence of multiphase sampling," Biometrics, The International Biometric Society, vol. 74(1), pages 27-39, March.
    4. Gilbert Peter B. & Blette Bryan S. & Hudgens Michael G. & Shepherd Bryan E., 2020. "Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial," Journal of Causal Inference, De Gruyter, vol. 8(1), pages 54-69, January.
    5. Layla Parast & Tianxi Cai & Lu Tian, 2023. "Testing for heterogeneity in the utility of a surrogate marker," Biometrics, The International Biometric Society, vol. 79(2), pages 799-810, June.
    6. Tyler J. VanderWeele, 2013. "Surrogate Measures and Consistent Surrogates," Biometrics, The International Biometric Society, vol. 69(3), pages 561-565, September.
    7. Ying Huang & Peter B. Gilbert & Julian Wolfson, 2013. "Design and Estimation for Evaluating Principal Surrogate Markers in Vaccine Trials," Biometrics, The International Biometric Society, vol. 69(2), pages 301-309, June.
    8. Zhichao Jiang & Shu Yang & Peng Ding, 2022. "Multiply robust estimation of causal effects under principal ignorability," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 84(4), pages 1423-1445, September.
    9. Gilbert Peter B. & Blette Bryan S. & Shepherd Bryan E. & Hudgens Michael G., 2020. "Post-randomization Biomarker Effect Modification Analysis in an HIV Vaccine Clinical Trial," Journal of Causal Inference, De Gruyter, vol. 8(1), pages 54-69, January.
    10. Zhichao Jiang & Peng Ding & Zhi Geng, 2016. "Principal causal effect identification and surrogate end point evaluation by multiple trials," Journal of the Royal Statistical Society Series B, Royal Statistical Society, vol. 78(4), pages 829-848, September.
    11. Layla Parast & Lu Tian & Tianxi Cai, 2020. "Assessing the value of a censored surrogate outcome," Lifetime Data Analysis: An International Journal Devoted to Statistical Methods and Applications for Time-to-Event Data, Springer, vol. 26(2), pages 245-265, April.
    12. Michael R. Elliott & Anna Conlon & Yun Li, 2013. "Discussion on “Surrogate Measures and Consistent Surrogates”," Biometrics, The International Biometric Society, vol. 69(3), pages 565-569, September.
    13. Guosheng Yin & Yu Shen, 2005. "Adaptive Design and Estimation in Randomized Clinical Trials with Correlated Observations," Biometrics, The International Biometric Society, vol. 61(2), pages 362-369, June.
    14. Ghosh, Debashis, 2012. "A causal framework for surrogate endpoints with semi-competing risks data," Statistics & Probability Letters, Elsevier, vol. 82(11), pages 1898-1902.
    15. Gilbert Peter B. & Gabriel Erin E. & Huang Ying & Chan Ivan S.F., 2015. "Surrogate Endpoint Evaluation: Principal Stratification Criteria and the Prentice Definition," Journal of Causal Inference, De Gruyter, vol. 3(2), pages 157-175, September.
    16. Bartolucci, Francesco & Grilli, Leonardo, 2011. "Modeling Partial Compliance Through Copulas in a Principal Stratification Framework," Journal of the American Statistical Association, American Statistical Association, vol. 106(494), pages 469-479.
    17. Emily K. Roberts & Michael R. Elliott & Jeremy M. G. Taylor, 2023. "Solutions for surrogacy validation with longitudinal outcomes for a gene therapy," Biometrics, The International Biometric Society, vol. 79(3), pages 1840-1852, September.
    18. Michael Perlman & Lang Wu, 2006. "Some Improved Tests for Multivariate One-Sided Hypotheses," Metrika: International Journal for Theoretical and Applied Statistics, Springer, vol. 64(1), pages 23-39, August.
    19. Corwin M. Zigler & Thomas R. Belin, 2012. "A Bayesian Approach to Improved Estimation of Causal Effect Predictiveness for a Principal Surrogate Endpoint," Biometrics, The International Biometric Society, vol. 68(3), pages 922-932, September.
    20. Taddesse Kassahun & Eshetu Wencheko & Arne C. Bathke, 2023. "Nonparametric directional testing for multivariate problems in conjunction with a closed testing principle," Statistical Methods & Applications, Springer;Società Italiana di Statistica, vol. 32(2), pages 349-363, June.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:stabio:v:12:y:2020:i:3:d:10.1007_s12561-020-09275-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.